These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 30373410)
1. The immune microenvironment in vulvar (pre)cancer: review of literature and implications for immunotherapy. Abdulrahman Z; Kortekaas KE; De Vos Van Steenwijk PJ; Van Der Burg SH; Van Poelgeest MI Expert Opin Biol Ther; 2018 Dec; 18(12):1223-1233. PubMed ID: 30373410 [TBL] [Abstract][Full Text] [Related]
2. High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status. Kortekaas KE; Santegoets SJ; Abdulrahman Z; van Ham VJ; van der Tol M; Ehsan I; van Doorn HC; Bosse T; van Poelgeest MIE; van der Burg SH J Immunother Cancer; 2019 Sep; 7(1):236. PubMed ID: 31481117 [TBL] [Abstract][Full Text] [Related]
4. Molecular events in the pathogenesis of vulvar squamous cell carcinoma. Xing D; Fadare O Semin Diagn Pathol; 2021 Jan; 38(1):50-61. PubMed ID: 33032902 [TBL] [Abstract][Full Text] [Related]
5. Alterations in classical and nonclassical HLA expression in recurrent and progressive HPV-induced usual vulvar intraepithelial neoplasia and implications for immunotherapy. van Esch EM; Tummers B; Baartmans V; Osse EM; Ter Haar N; Trietsch MD; Hellebrekers BW; Holleboom CA; Nagel HT; Tan LT; Fleuren GJ; van Poelgeest MI; van der Burg SH; Jordanova ES Int J Cancer; 2014 Aug; 135(4):830-42. PubMed ID: 24415578 [TBL] [Abstract][Full Text] [Related]
6. Pre-existing inflammatory immune microenvironment predicts the clinical response of vulvar high-grade squamous intraepithelial lesions to therapeutic HPV16 vaccination. Abdulrahman Z; de Miranda N; van Esch EMG; de Vos van Steenwijk PJ; Nijman HW; J P Welters M; van Poelgeest MIE; van der Burg SH J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32169871 [TBL] [Abstract][Full Text] [Related]
7. Intraepithelial macrophage infiltration is related to a high number of regulatory T cells and promotes a progressive course of HPV-induced vulvar neoplasia. van Esch EM; van Poelgeest MI; Trimbos JB; Fleuren GJ; Jordanova ES; van der Burg SH Int J Cancer; 2015 Feb; 136(4):E85-94. PubMed ID: 25220265 [TBL] [Abstract][Full Text] [Related]
8. Increased osteopontin expression is associated with progression from vulvar precancerous lesions to vulvar squamous cell carcinoma. Wu Z; Shen Y; Gong K; Wu Z; Zhang T; Zhang X; Li S Arch Gynecol Obstet; 2014 Mar; 289(3):637-44. PubMed ID: 23978873 [TBL] [Abstract][Full Text] [Related]
9. Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma. Del Pino M; Rodriguez-Carunchio L; Ordi J Histopathology; 2013 Jan; 62(1):161-75. PubMed ID: 23190170 [TBL] [Abstract][Full Text] [Related]
10. Specific intraepithelial localization of mast cells in differentiated vulvar intraepithelial neoplasia and its possible contribution to vulvar squamous cell carcinoma development. van de Nieuwenhof HP; Hebeda KM; Bulten J; Otte-Holler I; Massuger LF; de Hullu JA; van Kempen LC Histopathology; 2010 Sep; 57(3):351-62. PubMed ID: 20727018 [TBL] [Abstract][Full Text] [Related]
11. Review of squamous premalignant vulvar lesions. van de Nieuwenhof HP; van der Avoort IA; de Hullu JA Crit Rev Oncol Hematol; 2008 Nov; 68(2):131-56. PubMed ID: 18406622 [TBL] [Abstract][Full Text] [Related]
12. Monocyte infiltration is an independent positive prognostic biomarker in vulvar squamous cell carcinoma. Abdulrahman Z; Kortekaas KE; Welters MJP; van Poelgeest MIE; van der Burg SH Cancer Immunol Immunother; 2024 Jul; 73(9):166. PubMed ID: 38954042 [TBL] [Abstract][Full Text] [Related]
14. The forgotten woman's cancer: vulvar squamous cell carcinoma (VSCC) and a targeted approach to therapy. Clancy AA; Spaans JN; Weberpals JI Ann Oncol; 2016 Sep; 27(9):1696-705. PubMed ID: 27329249 [TBL] [Abstract][Full Text] [Related]
15. Squamous precursor lesions of the vulva: current classification and diagnostic challenges. Hoang LN; Park KJ; Soslow RA; Murali R Pathology; 2016 Jun; 48(4):291-302. PubMed ID: 27113549 [TBL] [Abstract][Full Text] [Related]
16. Somatic Mutation Profiling in Premalignant Lesions of Vulvar Squamous Cell Carcinoma. Zięba S; Pouwer AW; Kowalik A; Zalewski K; Rusetska N; Bakuła-Zalewska E; Kopczyński J; Pijnenborg JMA; de Hullu JA; Kowalewska M Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664330 [TBL] [Abstract][Full Text] [Related]
17. Genetic and epigenetic changes in vulvar squamous cell carcinoma and its precursor lesions: a review of the current literature. Trietsch MD; Nooij LS; Gaarenstroom KN; van Poelgeest MI Gynecol Oncol; 2015 Jan; 136(1):143-57. PubMed ID: 25448458 [TBL] [Abstract][Full Text] [Related]
18. Vulvar squamous cell carcinoma arising on human papillomavirus-independent precursors mimicking high-grade squamous intra-epithelial lesion: a distinct and highly recurrent subtype of vulvar cancer. Carreras-Dieguez N; Saco A; Del Pino M; Pumarola C; Del Campo RL; Manzotti C; Garcia A; Marimon L; Diaz-Mercedes S; Fuste P; Rodrigo-Calvo MT; Vega N; Torné A; Rakislova N Histopathology; 2023 Apr; 82(5):731-744. PubMed ID: 36593525 [TBL] [Abstract][Full Text] [Related]
19. Expression of coinhibitory receptors on T cells in the microenvironment of usual vulvar intraepithelial neoplasia is related to proinflammatory effector T cells and an increased recurrence-free survival. van Esch EM; van Poelgeest MI; Kouwenberg S; Osse EM; Trimbos JB; Fleuren GJ; Jordanova ES; van der Burg SH Int J Cancer; 2015 Feb; 136(4):E95-106. PubMed ID: 25220367 [TBL] [Abstract][Full Text] [Related]
20. Primary vulvar squamous cell carcinomas with high T cell infiltration and active immune signaling are potential candidates for neoadjuvant PD-1/PD-L1 immunotherapy. Kortekaas KE; Santegoets SJ; Tas L; Ehsan I; Charoentong P; van Doorn HC; van Poelgeest MIE; Mustafa DAM; van der Burg SH J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34716208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]